Bavarian Nordic’s mpox vaccine, Jynneos (MVA-BN), is set to be trialled in pregnant and breastfeeding women and infants. The Phase III trial (PregInPoxVac) will enrol around 350 pregnant women and 250 ...

An initial 899,000 vaccine doses have been allocated for nine countries across Africa that have been hit hard by the current mpox surge, the WHO and other health organizations say.

Last week African countries reported 2,532 new mpox cases, mostly in the Democratic Republic of the Congo (DRC) and Burundi, ...

The Africa Centers for Disease Control and Prevention has estimated Congo needs at least 3 million mpox vaccines to stop the ...

WHO has allocated 899,000 mpox vaccine doses to nine African nations, prioritising those hit hardest by the latest outbreak.

Results from this study could support an extension of the current approval of MVA-BN to include children from 2 years of age ...

The Defense Health Agency and military services are working to make the mpox vaccine available for those at risk ... the ...

In September, after facing criticism on moving too slowly on vaccines, the World Health Organization cleared Bavarian ...

Cases have also been diagnosed in Thailand, Sweden and Germany. In mid-September, Britain purchased more than 150,000 doses ...

Bavarian Nordic gets $63 million US government order for small pox, mpox vaccine September 24, 2024 Future of Healthcategory Bavarian says mpox vaccine approved by EU regulator for adolescents ...

The WHO has declared a global health emergency over a new strain of mpox rapidly spreading in Africa. Here’s what you need to ...